Sero-prevalence of Anti-pertussis Antibodies and Disease Awareness Among Spanish Healthcare Professionals

GlaxoSmithKline (GSK)

Status: Completed

Conditions: Pertussis

Treatments: Procedure: Blood sample; Other: Data collection

Study type: Observational

Funder types: Industry

Identifiers

NCT01706224

115539

Details and patient eligibility

About

This study aims to determine the sero-prevalence of anti-pertussis antibodies among healthcare professionals at hospital centres in Spain.

Enrollment: 757 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Written informed consent obtained from the subject.
• Subjects who the investigator believes that they can and will comply with the requirements of the protocol.
• Male and female healthcare professionals aged ≥18 years from selected hospitals.
• Healthcare professionals in frequent contact with patients in the hospitals.
• Agreeing for collection of a blood sample for the study.

Exclusion criteria

• Medical students working as healthcare professionals.

Trial design

757 participants in 4 patient groups

Group A

Description:

Subjects in this group will be all physicians actively working at hospital centres in Spain.

Treatment:

Procedure: Blood sample

Other: Data collection

Other: Data collection

Group B

Description:

Subjects in this group will be all nurses actively working at hospital centres in Spain.

Treatment:

Procedure: Blood sample

Other: Data collection

Other: Data collection

Group C

Description:

Subjects in this group will be all ancillary nursing professionals actively working at hospital centres in Spain.

Treatment:

Procedure: Blood sample

Other: Data collection

Other: Data collection

Group D

Description:

Subjects in this group will be all midwives actively working at hospital centres in Spain.

Treatment:

Procedure: Blood sample

Other: Data collection

Other: Data collection